Atlas FDA

MYNX VASCULAR CLOSURE DEVICE

FDA premarket approval P040044/S001 · decided 2007-05-16

Approval details

PMA number
P040044
Supplement
S001
Supplement type
Panel Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MYNX VASCULAR CLOSURE DEVICE
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2006-04-06
Decision date
2007-05-16
Days to decision
405 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
APPROVAL FOR THE MYNX VASCULAR CLOSURE SYSTEM. THE DEVICE IS INDICTED FOR USE TO SEAL FEMORAL ARTERIAL ACCESS SITES WHILE REDUCING TIMES TO HEMOSTASIS AND AMBULATION IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC OR INTERVENTIONAL ENDOVASCULAR PROCEDURES UTILIZING A 5F, 6F, OR 7F PROCEDURAL SHEATH.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.